Atovaquon/Proguanil Teva

Atovaquone/Proguanil Teva is a combination medication used to prevent and treat malaria. This oral medication is manufactured by Teva Nederland B.V. and is suitable for oral use.

Atovaquone/Proguanil Teva is primarily used for the prevention and treatment of malaria, a disease caused by parasites transmitted through mosquito bites. It is often prescribed for travelers to areas where malaria is prevalent. This medication works by interfering with the growth of parasites in the red blood cells.

Common effects of Atovaquone/Proguanil Teva may include nausea, vomiting, diarrhea, and headache. Some users might experience abdominal pain or loss of appetite. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Atovaquone/Proguanil Teva should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment to ensure effectiveness. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Atovaquone/Proguanil Teva may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. Alcohol consumption should be avoided as it may increase the risk of side effects. Always consult a healthcare professional before starting any new medication.